1.9658

0.81% 0.0158

After Hours: 1.97 0.0042 +0.21%

Mei Pharma Inc (MEIP)

Overview News Price History Option Chain Financials Discussions Forecast Stock Split

Mei Pharma Inc stock is traded at $1.9658, with a volume of 4,080. It is up +0.81% in the last 24 hours and down -15.08% over the past month. MEI Pharma Inc is focused on the clinical development of novel therapies for cancer. The company's clinical drug candidate includes Pracinostat, an orally available histone deacetylase inhibitor for the treatment of patients with acute myeloid leukemia and myelodysplastic syndrome. Its clinical development portfolio also includes Zandelisib, an oral inhibitor of phosphatidylinositide 3-kinase delta for the treatment of patients with recurrent chronic lymphocytic leukemia or follicular non-Hodgkin's lymphoma; and ME-344, an isoflavone-based mitochondrial inhibitor for the treatment of HER2-negative breast cancer and Pracinostat, an oral histone deacetylase inhibitor. Geographically, all the business activities function through the region of the United States.

Previous Close:

$1.95

Open:

$1.94

24h Volume:

4,080

Relative Volume:

0.41

Market Cap:

$12.73M

Revenue:

$105.38M

Net Income/Loss:

$17.78M

P/E Ratio:

0.7363

EPS:

2.67

Net Cash Flow:

$-50.48M

1W Performance:

+4.56%

1M Performance:

-15.08%

6M Performance:

-28.52%

1Y Performance:

-40.61%

1-Day Range:

$1.94

$1.995

1-Week Range:

$1.46

$2.07

52-Week Range:

$1.46

$4.10

Mei Pharma Inc Stock (MEIP) Company Profile

Name

Mei Pharma Inc

Sector

Healthcare (1151)

Industry

Biotechnology (660)

Phone

858-369-7100

Address

11455 EL CAMINO REAL, SAN DIEGO, CA

Employee

Twitter

@MEI_Pharma

Next Earnings Date

2024-11-07

Latest SEC Filings

MEIP's Discussions on Twitter

Compare MEIP with other stocks

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
MEIP Mei Pharma Inc	1.9658	12.73M	105.38M	17.78M	-50.48M	2.67
VRTX Vertex Pharmaceuticals Inc	489.10	127.47B	11.02B	-535.60M	-978.00M	-2.20
REGN Regeneron Pharmaceuticals Inc	563.16	62.43B	14.20B	4.41B	3.54B	38.28
ARGX Argen X Se Adr	596.20	37.03B	2.19B	833.04M	-1.28B	12.71
ALNY Alnylam Pharmaceuticals Inc	234.56	31.06B	2.25B	-278.16M	-42.59M	-2.17
ONC Beigene Ltd Adr	230.98	26.16B	3.81B	-644.79M	-669.77M	-6.24

Mei Pharma Inc Stock (MEIP) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Jul-23-24	Downgrade	Laidlaw	Buy → Hold
Mar-25-22	Downgrade	Jefferies	Buy → Hold
Mar-25-22	Downgrade	Stifel	Buy → Hold
Mar-25-22	Downgrade	Wells Fargo	Overweight → Equal Weight
Feb-03-22	Initiated	Jefferies	Buy
Sep-22-20	Initiated	Alliance Global Partners	Buy
May-29-20	Initiated	SunTrust	Buy
Dec-20-18	Initiated	H.C. Wainwright	Buy
Jul-27-18	Upgrade	Stifel	Hold → Buy
Jul-13-18	Initiated	SunTrust	Buy
Apr-18-16	Reiterated	Wedbush	Neutral
Mar-23-15	Downgrade	ROTH Capital	Buy → Neutral
Dec-18-14	Reiterated	ROTH Capital	Buy
Oct-16-14	Reiterated	ROTH Capital	Buy
Jul-08-14	Resumed	Brean Capital	Buy
Oct-22-13	Reiterated	Stifel	Buy
Apr-15-13	Initiated	Stifel	Buy

View All

Mei Pharma Inc Stock (MEIP) Latest News

Apr 16, 2025

MEI Pharma (NASDAQ:MEIP) Stock Passes Below Two Hundred Day Moving Average – Here’s What Happened - Defense World

Apr 16, 2025

StockNews.com Initiates Coverage on MEI Pharma (NASDAQ:MEIP) - Defense World

Apr 16, 2025

Apr 09, 2025

MEI Pharma stock hits 52-week low at $1.83 amid market challenges - Investing.com

Apr 09, 2025

Apr 08, 2025

MEI Pharma stock hits 52-week low at $1.83 amid market challenges By Investing.com - Investing.com South Africa

Apr 08, 2025

Follicular Lymphoma Market to Reach New Heights in Growth by 2034, DelveInsight Predicts | Roche, BeiGene, Kite Pharma, Incyte Corp, AstraZeneca, MEI Pharma, Novartis, Innovent Biologics, Regeneron - Barchart.com

Apr 02, 2025

Virtu Financial LLC Purchases Shares of 10,744 MEI Pharma, Inc. (NASDAQ:MEIP) - Defense World

Apr 02, 2025

Apr 01, 2025

MEI Pharma (NASDAQ:MEIP) Now Covered by Analysts at StockNews.com - The AM Reporter

Apr 01, 2025

Mar 31, 2025

StockNews.com Begins Coverage on MEI Pharma (NASDAQ:MEIP) - Defense World

Mar 31, 2025

Mar 28, 2025

MEI Pharma stock hits 52-week low at $2.27 amid market challenges - Investing.com Australia

Mar 28, 2025

Mar 23, 2025

MEI Pharma (NASDAQ:MEIP) Coverage Initiated by Analysts at StockNews.com - Defense World

Mar 23, 2025

Mar 18, 2025

MEI Pharma stock hits 52-week low at $2.28 amid market challenges - Investing.com Australia

Mar 18, 2025

Mar 17, 2025

MEI Pharma stock hits 52-week low at $2.28 amid market challenges By Investing.com - Investing.com South Africa

Mar 17, 2025

Mar 07, 2025

MEI Pharma, Inc. to Host Earnings Call - ACCESS Newswire

Mar 07, 2025

Mar 06, 2025

10 Cheap Chinese Stocks to Buy Now - Insider Monkey

Mar 06, 2025

Mar 05, 2025

11 Best Undervalued Stocks to Invest in Now - Insider Monkey

Mar 05, 2025

Feb 26, 2025

The Polycythemia Vera Market Landscape Heats Up Amid Rising Competition Among Pharma Companies | DelveInsight - The Malaysian Reserve

Feb 26, 2025

Feb 19, 2025

C-COM Antenna Receives Eutelsat Type Approval - The Globe and Mail

Feb 19, 2025

Marginal Zone Lymphoma Clinical Trials and Studies: EMA, PDMA, FDA Approvals, Mechanism of Action, ROA, NDA, IND, and Companies - The Globe and Mail

Feb 19, 2025

Alarm.com (ALRM) Q4 Earnings: What To Expect - The Globe and Mail

Feb 19, 2025

Why Tight Corporate-U.S. Treasury Yield Spreads Signal Good News for Ag Markets Prices - The Globe and Mail

Feb 19, 2025

Feb 13, 2025

MEI Pharma Reports Increased Losses Amid Strategic Shift - TipRanks

Feb 13, 2025

Feb 12, 2025

MEI Pharma Reports Second Quarter Fiscal Year 2025 Cash Position - BioSpace

Feb 12, 2025